Background Previous studies have disclosed that serum amyloid A (SAA) is likely involved
in the lung cancer pathogenesis and progression. We performed a systematic evaluation�…

BACKGROUND: The authors investigated whether early stage lung cancer could be
identified by proteomic analyses of plasma. METHODS: For the first case‐control study�…

Two hundred and eighteen serum samples from 175 lung cancer patients and 43 healthy
individuals were analyzed by using Surface Enhaced Laser Desorption/Ionization Time of�…

Background: Lung cancer is known as the top cancer killer in most developed countries.
However, there is currently no promising diagnostic or prognostic biomarker for lung cancer�…

Background Published studies showed divergent results of the prognostic value of serum
amyloid A protein (SAA) in patients with different cancers. Therefore, we conducted this meta�…

Objective To identify serum diagnosis or progression biomarkers in patients with lung cancer
using protein chip profiling analysis. Method Profiling analysis was performed on 450 sera�…

Objective Increased serum amyloid A (SAA) levels have been investigated in various human
malignancies, but a consistent perspective has not been established to date. This study�…

Lung cancer is recently regarded as an overhealed inflammatory disease. Serum amyloid A
(SAA) is known as an acute phase protein, but it is likely involved in the cancer�…

Background Previous studies have demonstrated that serum amyloid A (SAA) levels are
correlated with the clinical outcomes of solid tumors. However, the available data have not�…

Background Elevated levels of serum C‐reactive protein (CRP) have been reported to have
prognostic significance in lung cancer patients. This study aimed to further identify CRP�…